HCPCS Level IIdrugActive
J2778
Ranibizumab injection
BETOS: O1E
Effective: 2008-01-01
Referenced in 3 policies
Description
Injection, ranibizumab, 0.1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Lucentis
Manufacturer
Genentech, Inc.
HCPCS Dosage
0.1 mg
Billing Units
5.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.